Phio Pharmaceuticals Corp. · NASDAQ:PHIO
Bitterman Robert J had 68,550 Phio Pharmaceuticals Corp. shares withheld for tax (Form 4)
Traded Sep 11, 2026 · Filed Sep 15, 2026
On Sep 11, 2026, Bitterman Robert J (Director, Chairman, Pres. & CEO) had 68,550 Phio Pharmaceuticals Corp. shares withheld for tax at US$1.03 for US$70,607, leaving 362,871 shares. Filed Sep 15, 2026 (Form 4).
- Withheld for tax
- 68,550 shares
- Price
- US$1.03
- Value
- US$70,607
- Holding after
- 362,871 shares
- Trading plan
- No
- Role
- Director, Chairman, Pres. & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Common Stock, $.0001 par value | Shares withheld for tax | 68,550 | US$1.03 | 362,871 | Direct |
Source
Related
- Phio Pharmaceuticals Corp.
- Bitterman Robert J
- Phio Pharmaceuticals Corp. shareholders
- Form 4 · Bitterman Robert J · Sep 29, 2026
- Form 4 · Bitterman Robert J · Sep 23, 2026
- Form 4 · Bitterman Robert J · Aug 19, 2026
- Form 4 · Bitterman Robert J · Jun 29, 2026
- Form 4 · Plott Ronald Todd · Sep 30, 2026
- Form 4 · Plott Ronald Todd · Sep 29, 2026
- Form 4 · Carson Lisa Cabott · Sep 29, 2026
- Form 4 · Bradford Patricia A · Sep 25, 2026
- Form 4 · Bradford Patricia A · Sep 16, 2026